BIOS Capital Management as of Dec. 31, 2025
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 74.4 | $62M | 10M | 6.12 | |
| Cognition Therapeutics (CGTX) | 9.8 | $8.1M | 6.0M | 1.35 | |
| Ocuphire Pharma (IRD) | 9.0 | $7.4M | 3.7M | 2.01 | |
| Lantern Pharma (LTRN) | 3.7 | $3.1M | 1.0M | 3.03 | |
| Rein Therapeutics Com New (RNTX) | 2.4 | $2.0M | 1.7M | 1.16 | |
| In8bio Com New (INAB) | 0.7 | $593k | 253k | 2.34 |
